Gelesis' oral treatment for weight management showed real-world effectiveness in new data presented at the american diabetes association's annual conference

Boston--(business wire)---- $gls #earnings--gelesis, the maker of plenity for weight management, presented a late-breaking poster presentation at the american diabetes association's (ada) 2023 annual meeting showing the real-world effectiveness of the company's oral superabsorbent hydrogel across 894 people who were prescribed plenity for weight management. consistent with previous clinical studies, responders demonstrated clinically significant weight loss at 6 months. plenity is an orally administered, non-stim.
GLS Ratings Summary
GLS Quant Ranking